Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 65162-849

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 65162-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

29516af3-figure-01 (Valsartan And Hydrochlorothiazide Tablets Usp 1)

29516af3-figure-01 (Valsartan And Hydrochlorothiazide Tablets Usp 1)
This text appears to be a part of a table or a graph related to blood pressure measurements. The numbers indicate a range of values for systolic blood pressure (SBP) in millimeters of mercury (mmHg). The specific context or purpose of this information is not clear based on the provided text.*
FDA Label Image

Fg (Valsartan And Hydrochlorothiazide Tablets Usp 10)

Fg (Valsartan And Hydrochlorothiazide Tablets Usp 10)
This text is a description of a medication called Valsartan and Hydrochlorothiazide Tablets, USP. Each film-coated tablet contains 320 mg of Valsartan and 125 mg of Hydrochlorothiazide. The usual dosage is indicated in the package insert. It is recommended to store the medication at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) to protect from moisture. The medication should be dispensed in a tight container, as defined by the USP standards. It is advised to keep this medication out of the reach of children. The medication is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
FDA Label Image

Nb (Valsartan And Hydrochlorothiazide Tablets Usp 11)

Nb (Valsartan And Hydrochlorothiazide Tablets Usp 11)
Not available.*
FDA Label Image

29516af3-figure-02 (Valsartan And Hydrochlorothiazide Tablets Usp 2)

FDA Label Image

29516af3-figure-03 (Valsartan And Hydrochlorothiazide Tablets Usp 3)

29516af3-figure-03 (Valsartan And Hydrochlorothiazide Tablets Usp 3)
This text appears to be a collection of numbers and abbreviations related to blood pressure medications. It mentions a target systolic blood pressure (SBP) of less than 130 mmHg, and the use of Valsartan and Hydrochlorothiazide (HCTZ) in specific dosages. The text also includes a range of values for baseline SBP measurements. However, due to the lack of coherent and readable information, a meaningful description cannot be provided.*
FDA Label Image

29516af3-figure-04 (Valsartan And Hydrochlorothiazide Tablets Usp 4)

FDA Label Image

Q (Valsartan And Hydrochlorothiazide Tablets Usp 5)

FDA Label Image

R (Valsartan And Hydrochlorothiazide Tablets Usp 6)

FDA Label Image

We (Valsartan And Hydrochlorothiazide Tablets Usp 7)

FDA Label Image

Nm (Valsartan And Hydrochlorothiazide Tablets Usp 8)

FDA Label Image

Er (Valsartan And Hydrochlorothiazide Tablets Usp 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.